Annual Drug Patent Expirations for PEPAXTO Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA. There are five patents protecting this drug. This drug has…
The post New patent for Oncopeptides Ab drug PEPAXTO appeared first on Drug…
Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. There are six patents protecting this drug. This drug has…
The post New patent for Deciphera Pharms drug QINLOCK appeared first on Dru…
Annual Drug Patent Expirations for FERRIPROX Ferriprox is a drug marketed by Chiesi and is included in three NDAs. It is available from two suppliers. There are four patents protecting…
The post New patent for Chiesi drug FERRIPROX appeared first on Dr…
Annual Drug Patent Expirations for VOSEVI Vosevi is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are eighteen…
The post New patent for Gilead Sciences drug VOSEVI appeared first on DrugPate…
This chart shows the pharmaceutical companies with the most patents in European Patent Office. Patents must be filed in each country (or, in some cases regional patent office) where patent…
The post Which pharmaceutical companies have the most drug pat…
Which pharmaceutical companies have the most drug patents in European Patent Office? Read Post »
This chart shows the drugs with the most patents in Israel. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Israel? …
Which pharmaceutical drugs have the most drug patents in Israel? Read Post »
This chart shows the drugs with the most patents in Peru. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Peru? appe…
Which pharmaceutical drugs have the most drug patents in Peru? Read Post »
Annual Drug Patent Expirations for GLEEVEC Gleevec is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There is one patent protecting…
The post New patent expiration for Novartis drug GLEEVEC appeared first on…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Ireland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Ireland? Read Post »
Annual Drug Patent Expirations for SYMJEPI Symjepi is a drug marketed by Adamis Pharms Corp and is included in one NDA. SYMJEPI drug price trends. The generic ingredient in SYMJEPI…
The post New patent for Adamis Pharms drug SYMJEPI appeared first on D…
Get new actionable insights and updates from BiotechBlog
